查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1479992

感染控制市场评估：依类型、产品、应用、最终用户、分销管道和地区划分的机会和预测（2017-2031）

Infection Control Market Assessment, By Type, By Product, By Application, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 234 Pages | 商品交期: 3-5个工作天内

价格
全球感染控制市场规模预计将从2023年的1,062.1亿美元成长到2031年的1,713.4亿美元，在2024-2031年的预测期内复合年增长率预计将成长6.16%。

该市场的成长受到多重抗药性细菌日益增长的威胁、医疗保健行业不断增长的需求、不断增加的临床和外科手术以及减少急性呼吸道疾病威胁的需求的支持。方针。

增加医疗支出是全球感染控制市场的主要趋势之一。 美国医学会估计，2022 年美国医疗保健支出将增加至 4.4 兆美元（人均 13,493 美元）。 对感染控制措施的需求增加也是由于医疗环境的严格性提高。 由于外科手术的需求不断增长和人口老化，医疗机构正在采用严格的清洁方法。 这增加了对强大的感染控制产品和服务的需求。

预计技术创新和人工智慧也将在支持未来几年市场成长方面发挥关键作用。 自动卫生分配器、紫外线消毒系统和机器人清洁机等创新越来越受欢迎。 进步和产品创新预计将有助于简化感染控制并为市场提供利润丰厚的成长机会。

全球不同地区感染控制计画的实施也是推动全球感染控制市场成长的主要因素。 例如，印度拉杰普拉雅利安护理研究所与穆兰普尔霍米巴巴癌症医院合作，于 2024 年 5 月进行了感染控制和预防示范。 讲者反思了感染控制和预防的重要性，并详细介绍了科学方法如何支持预防医院感染并减少微生物传播给医护人员、病人和访客的威胁。

外科手术需求的不断增长推动了市场需求：

各种慢性疾病的日益流行正在推动世界各地对外科手术的需求，并增加对感染控制产品和服务的需求。 手术部位感染占医院感染的 20%，全球盛行率介于 2.5% 至 41.9% 之间。 由于对有效治疗各种健康状况的手术干预的需求不断增加，医疗机构正在增加在维持无菌环境方面的投资，感染控制产品和服务也在增加。 微创外科手术的兴起增加了对先进灭菌製程和服务的需求。 由于严格的法规以及对改善患者健康的日益关注，卫生和清洁变得越来越重要，这进一步增加了市场需求。

人工智慧与感染控制的结合带来了利润丰厚的成长机会：

人工智慧与感染控制的成功整合将使医疗机构能够认识到他们所面临的问题，并确定人工智慧是否可以提供有效的解决方案。 人工智慧系统有望减轻口罩合规审核和环境清洁等重复性任务，并为特定患者群体的大数据分析提供机会。 在过去的几年里，人工智慧已经将清洁工作从手动擦洗髮展到能够决定将工作重点放在哪里的智慧机器人。 在人工智慧的帮助下，机器人还可以即时监测空气和环境质量，并定位需要额外输入的位置。 人工智慧也协助专业人员简化感染控制操作，扩大全球感染控制市场规模。

本报告调查了全球感染控制市场，提供了市场定义和概述、市场规模趋势和预测、各个细分市场/地区/主要国家的详细分析、行业结构以及对市场成长的影响，它总结了因素分析、案例。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第四章全球感染控制市场展望

  • 市场规模/预测
  • 依类型
    • 服务
    • 设备
    • 消耗品
  • 依产品
    • 灭菌产品
    • 清洁消毒用品
    • 个人防护屏障
    • 内视镜再处理产品
    • 抗菌表面
    • 其他
  • 依用途
    • 手术器械
    • 内视镜
    • 超音波探头
    • 其他
  • 依最终用户
    • 医院
    • 诊所
    • 诊断实验室
    • 医疗器材公司
    • 生技和製药公司
    • 其他
  • 依分销管道
    • 零售
    • 第三方供应商
    • 直接出价
  • 依地区
    • 北美
    • 欧洲
    • 南美洲
    • 亚太地区
    • 中东/非洲
  • 各公司的市占率

第 6 章全球感染控制市场展望：依地区

  • 北美
  • 欧洲
  • 南美洲
  • 亚太地区
  • 中东/非洲

第 6 章市场映射

  • 依类型
  • 依产品
  • 依用途
  • 依最终用户
  • 依分销管道
  • 依地区

第七章宏观环境/产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

  • 生长促进因素
  • 生长抑制因子（问题/限制）

第 9 章监理架构与创新

  • 专利情况
  • 监理机关的核准
  • 创新/新兴技术

第十章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家参与公司）
  • 专利分析（如果适用）

第11章价格分析

第 12 章案例研究

第十三章主要公司展望

  • M Company
  • Getinge AB
  • Steric Plc
  • Sotera Health
  • Advanced Sterilization Products, Inc.
  • MATACHANA GROUP
  • MMM Group
  • Belimed AG
  • Halyard Health (Owens & Minor, Inc.)
  • Ecolab Inc.

第 14 章策略建议

第十五章关于我们公司/免责声明

Product Code: MX11337

Global infection control market is projected to witness a CAGR of 6.16% during the forecast period 2024-2031F, growing from USD 106.21 billion in 2023 to USD 171.34 billion in 2031F. The market's growth is supported by the escalating threat of multidrug-resistant organisms, rising requirements from the healthcare industry, increasing number of clinical and surgical procedures, and the introduction of stringent guidelines by various regulatory bodies to reduce the threat of acute respiratory diseases.

Increasing healthcare spending is one of the major global infection control market trends. According to the estimates of the American Medical Association, health spending in the United States increased to USD 13,493 per capita or USD 4.4 trillion in 2022. The growing requirement for infection control measures can also be attributed to the increasing stringency in healthcare settings. Due to the rising requirement for surgical interventions and the growing geriatric population, healthcare establishments are adopting stringent cleaning practices, as the weakened immunity of such patients makes them more susceptible to various infections. Thus, this is propelling the demand for robust infection control products and services.

Technological innovations and artificial intelligence are also expected to play a crucial role in supporting the market's growth in the coming years. Innovations such as automated hygiene dispensers, ultraviolet disinfection systems, and robotic cleaners are gaining traction. Advancements and product innovations are expected to aid in streamlining infection control, providing lucrative growth opportunities for the market.

The introduction of infection control programs in various regions across the globe is another major factor boosting global infection control market growth. For instance, the Aryans Institute of Nursing, Rajpura, India, organized a demonstration of infection control and prevention in May 2024 in collaboration with the Homi Bhabha Cancer Hospital, Mullanpur, India. The speakers reflected on the importance of infection control and prevention and elaborated on how the scientific approach supports the prevention of hospital-acquired infections and reduces the threat of microorganisms spreading to healthcare providers, patients, and visitors.

Growing Requirement for Surgical Procedures Boosts Market Demand

The increasing prevalence of different chronic diseases is propelling the requirement for surgical intervention, augmenting the requirement for infection control products and services in various regions across the globe. Surgical site infections account for 20% of hospital-acquired infections, with a pooled prevalence of 2.5-41.9% globally. Due to the heightened requirement for surgical interventions for effective treatment of various health conditions, infection control products and services are increasing as healthcare institutes are increasingly investing in maintaining sterile environments. The rise in the number of minimally invasive surgeries, among other surgical procedures, necessitates the requirement for advanced sterilization processes and services. The growing prioritization of hygiene and cleanliness due to stringent regulations and increasing emphasis on enhancing patient health further augment market demand.

Integration of AI with Infection Control Provides Lucrative Growth Opportunities

The successful integration of artificial intelligence (AI) with infection control will allow medical institutions to recognize the problems they have and determine if artificial intelligence is able to provide an effective solution. AI systems are expected to offload repetitive tasks such as mask compliance auditing and environmental cleaning and offer opportunities for big data analytics of a specific patient group. Over the past years, artificial intelligence has evolved cleaning from manual scrubbing to intelligent robots that have the ability to determine where to focus. With the assistance of artificial intelligence, robots are also able to monitor the air and environment quality in real time and target areas that require additional inputs. Artificial intelligence will also aid professionals in streamlining infection control operations, bolstering the global infection control market size.

North America Accounts for a Significant Share of the Market

The expansion of the market in the region is supported by the strong presence of various market players in North America, the presence of a well-established healthcare infrastructure, and the increasing adoption of infection control technologies due to growing awareness. The rising prevalence of healthcare-associated infections, expansion of the geriatric population, and increasing number of clinics and hospitals are other major factors propelling the demand for infection control in North America. According to the estimates of the Centers for Disease Control, 1.7 million infections and 99,000 associated deaths occur in American hospitals every year. The increased investments by the leading market players towards novel product development and strategic partnerships and collaborations to promote innovations are further boosting the market's growth in North America. The surge in the requirement for surgical procedures due to the rising prevalence of chronic diseases and disorders is another major factor augmenting the demand for infection control products and services.

Demand for Consumable Expected to Witness Significant Increase

The increased demand for consumables can be attributed to the short life cycle and consistent usage of these products. Personal protective equipment is used to provide a barrier between healthcare providers and microorganisms, reducing the risk of exposure. The selection of the products is made after a thorough risk assessment. They should be checked regularly to ensure that their integrity has not been compromised and should be evaluated for the expiration date as well. The segment's growth is boosted by successful collaborations and acquisitions. In May 2024, KARAM Safety acquired Midas Safety India to strengthen their position in personal protective equipment in India.

Additionally, the service segment is also expected to witness significant growth in the coming years. The expansion of the service segment can be attributed to increasing awareness about the availability and benefits of such services and a growing inclination towards reducing expenditures in sectors, including food and beverages, pharmaceutical, biotechnology, and healthcare.

Hospitals Hold Significant Share in the Global Infection Control Market

The increasing construction of hospitals due to rapid population growth and the rising prevalence of chronic health conditions propel the demand for infection control products and services. According to the Delhi Economic Survey, the construction of 11 structural medical facilities, including hospitals, is underway, while various established hospitals are being upgraded. One of the major concerns in hospitals is the risk of infection from drug-resistant bacteria and bloodborne pathogens, among others, in the operating theatre. For instance, the frequent utilization of catheters bolsters the risk of UTIs. Thus, hospitals should be urged to adopt effective infection control equipment and services as they aid in stopping the spread of infections. Infection control is paramount in hospitals, as it helps protect both healthcare workers and patients from diseases.

Future Market Scenario (2024-2031F)

According to the global infection control market analysis, infection control will become the cornerstone of healthcare in the coming years for preventing the transmission of infections across medical settings. The focus on infection control is expected to grow due to the increasing prevalence of hospital-acquired infections and the rising emphasis on patient safety across the globe. Technological advancements and integration of the internet of things and automated systems are further expected to propel the expansion of the infection control market by aiding in optimizing sterilization methods. Innovations in sterilization systems will also aid healthcare professionals in overcoming the various challenges posed by complex and novel medical devices that may require varying sterilization approaches.

Key Players Landscape and Outlook

The major players operating in the global infection control market are 3M, Getinge AB, Steric Plc, Sotera Health, Advanced Sterilization Products, Inc., and MATACHANA GROUP. The expansion of the market is supported by increasing mergers and acquisitions. In October 2023, Medicom Group, one of the leading providers of infection control and prevention solutions, announced the acquisition of Humask portfolio. The transaction also included the intellectual property and technologies developed by the company. This partnership is expected to ensure the availability and continuity of Humask's wide range of innovative protective equipment.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Infection Control Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Type
    • 4.2.1.Services
      • 4.2.1.1.Infectious Waste Disposal
      • 4.2.1.2.Contract Sterilization
        • 4.2.1.2.1.E-Beam Sterilization
        • 4.2.1.2.2.Gamma Sterilization
        • 4.2.1.2.3.Ethylene Oxide Sterilization
        • 4.2.1.2.4.Others
    • 4.2.2.Equipment
      • 4.2.2.1.Sterilization Equipment
        • 4.2.2.1.1.Radiation Sterilization Equipment
        • 4.2.2.1.2.Filtration Sterilization Equipment
        • 4.2.2.1.3.Heat Sterilization Equipment
        • 4.2.2.1.4.Low Temperature Sterilization Equipment
        • 4.2.2.1.5.Liquid Sterilization Equipment
      • 4.2.2.2.Disinfectors
        • 4.2.2.2.1.Washers
        • 4.2.2.2.2.Endoscope Reprocessors
        • 4.2.2.2.3.Flushes
      • 4.2.2.3.Others
    • 4.2.3.Consumables
      • 4.2.3.1.Sterilization Consumables
      • 4.2.3.2.Disinfectants
      • 4.2.3.3.Personal Protective Equipment
      • 4.2.3.4.Others
  • 4.3.By Product
    • 4.3.1.Sterilization Products
    • 4.3.2.Cleaning and Disinfection Products
    • 4.3.3.Personal Protective Barriers
    • 4.3.4.Endoscope Reprocessing Products
    • 4.3.5.Anti-Microbial Surfaces
    • 4.3.6.Other Infection Control Products
  • 4.4.By Application
    • 4.4.1.Surgical Instruments
    • 4.4.2.Endoscopes
    • 4.4.3.Ultrasound Probes
    • 4.4.4.Others
  • 4.5.By End-user
    • 4.5.1.Hospitals
    • 4.5.2.Clinics
    • 4.5.3.Diagnostic Laboratories
    • 4.5.4.Medical Device Companies
    • 4.5.5.Biotechnology and Pharmaceutical Companies
    • 4.5.6.Others
  • 4.6.By Distribution Channel
    • 4.6.1.Retail Sales
    • 4.6.2.Third Party Distributors
    • 4.6.3.Direct Tender
  • 4.7.By Region
    • 4.7.1.North America
    • 4.7.2.South America
    • 4.7.3.Europe
    • 4.7.4.Asia-Pacific
    • 4.7.5.Middle East and Africa
  • 4.8.By Company Market Share (%), 2023

5.Global Infection Control Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Type
      • 5.1.2.1.Services
        • 5.1.2.1.1.Infectious Waste Disposal
        • 5.1.2.1.2.Contract Sterilization
          • 5.1.2.1.2.1.E-Beam Sterilization
          • 5.1.2.1.2.2.Gamma Sterilization
          • 5.1.2.1.2.3.Ethylene Oxide Sterilization
          • 5.1.2.1.2.4.Others
      • 5.1.2.2.Equipment
        • 5.1.2.2.1.Sterilization Equipment
          • 5.1.2.2.1.1.Radiation Sterilization Equipment
          • 5.1.2.2.1.2.Filtration Sterilization Equipment
          • 5.1.2.2.1.3.Heat Sterilization Equipment
          • 5.1.2.2.1.4.Low Temperature Sterilization Equipment
          • 5.1.2.2.1.5.Liquid Sterilization Equipment
        • 5.1.2.2.2.Disinfectors
          • 5.1.2.2.2.1.Washers
          • 5.1.2.2.2.2.Endoscope Reprocessors
          • 5.1.2.2.2.3.Flushes
        • 5.1.2.2.3.Others
      • 5.1.2.3.Consumables
        • 5.1.2.3.1.Sterilization Consumables
        • 5.1.2.3.2.Disinfectants
        • 5.1.2.3.3.Personal Protective Equipment
        • 5.1.2.3.4.Others
    • 5.1.3.By Product
      • 5.1.3.1.Sterilization Products
      • 5.1.3.2.Cleaning and Disinfection Products
      • 5.1.3.3.Personal Protective Barriers
      • 5.1.3.4.Endoscope Reprocessing Products
      • 5.1.3.5.Anti-Microbial Surfaces
      • 5.1.3.6.Other Infection Control Products
    • 5.1.4.By Application
      • 5.1.4.1.Surgical Instruments
      • 5.1.4.2.Endoscopes
      • 5.1.4.3.Ultrasound Probes
      • 5.1.4.4.Others
    • 5.1.5.By End-user
      • 5.1.5.1.Hospitals
      • 5.1.5.2.Clinics
      • 5.1.5.3.Diagnostic Laboratories
      • 5.1.5.4.Medical Device Companies
      • 5.1.5.5.Biotechnology and Pharmaceutical Companies
      • 5.1.5.6.Others
    • 5.1.6.By Distribution Channel
      • 5.1.6.1.Retail Sales
      • 5.1.6.2.Third Party Distributors
      • 5.1.6.3.Direct Tender
    • 5.1.7.United States*
      • 5.1.7.1.Market Size & Forecast
        • 5.1.7.1.1.By Value
        • 5.1.7.1.2.By Volume
      • 5.1.7.2.By Type
        • 5.1.7.2.1.Services
          • 5.1.7.2.1.1.Infectious Waste Disposal
          • 5.1.7.2.1.2.Contract Sterilization
          • 5.1.7.2.1.2.1.E-Beam Sterilization
          • 5.1.7.2.1.2.2.Gamma Sterilization
          • 5.1.7.2.1.2.3.Ethylene Oxide Sterilization
          • 5.1.7.2.1.2.4.Others
        • 5.1.7.2.2.Equipment
          • 5.1.7.2.2.1.Sterilization Equipment
          • 5.1.7.2.2.1.1.Radiation Sterilization Equipment
          • 5.1.7.2.2.1.2.Filtration Sterilization Equipment
          • 5.1.7.2.2.1.3.Heat Sterilization Equipment
          • 5.1.7.2.2.1.4.Low Temperature Sterilization Equipment
          • 5.1.7.2.2.1.5.Liquid Sterilization Equipment
          • 5.1.7.2.2.2.Disinfectors
          • 5.1.7.2.2.2.1.Washers
          • 5.1.7.2.2.2.2.Endoscope Reprocessors
          • 5.1.7.2.2.2.3.Flushes
          • 5.1.7.2.2.3.Others
        • 5.1.7.2.3.Consumables
          • 5.1.7.2.3.1.Sterilization Consumables
          • 5.1.7.2.3.2.Disinfectants
          • 5.1.7.2.3.3.Personal Protective Equipment
          • 5.1.7.2.3.4.Others
      • 5.1.7.3.By Product
        • 5.1.7.3.1.Sterilization Products
        • 5.1.7.3.2.Cleaning and Disinfection Products
        • 5.1.7.3.3.Personal Protective Barriers
        • 5.1.7.3.4.Endoscope Reprocessing Products
        • 5.1.7.3.5.Anti-Microbial Surfaces
        • 5.1.7.3.6.Other Infection Control Products
      • 5.1.7.4.By Application
        • 5.1.7.4.1.Surgical Instruments
        • 5.1.7.4.2.Endoscopes
        • 5.1.7.4.3.Ultrasound Probes
        • 5.1.7.4.4.Others
      • 5.1.7.5.By End-user
        • 5.1.7.5.1.Hospitals
        • 5.1.7.5.2.Clinics
        • 5.1.7.5.3.Diagnostic Laboratories
        • 5.1.7.5.4.Medical Device Companies
        • 5.1.7.5.5.Biotechnology and Pharmaceutical Companies
        • 5.1.7.5.6.Others
      • 5.1.7.6.By Distribution Channel
        • 5.1.7.6.1.Retail Sales
        • 5.1.7.6.2.Third Party Distributors
        • 5.1.7.6.3.Direct Tender
    • 5.1.8.Canada
    • 5.1.9.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Type
  • 6.2.By Product
  • 6.3.By Application
  • 6.4.By End-user
  • 6.5.By Distribution Channel
  • 6.6.By Region

7.Macro Environment and Industry Structure

  • 7.1.Supply Demand Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat From New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Regulatory Approvals
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.3M Company
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products and Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus and Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Getinge AB
  • 13.3.Steric Plc
  • 13.4.Sotera Health
  • 13.5.Advanced Sterilization Products, Inc.
  • 13.6.MATACHANA GROUP
  • 13.7.MMM Group
  • 13.8.Belimed AG
  • 13.9.Halyard Health (Owens & Minor, Inc.)
  • 13.10.Ecolab Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 3.Global Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 4.Global Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 5.Global Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 6.Global Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 8.Global Infection Control Market Share (%), By Region, 2017-2031F
  • Figure 9.North America Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 10.North America Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 11.North America Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 12.North America Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 13.North America Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 14.North America Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 15.North America Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 16.North America Infection Control Market Share (%), By Country, 2017-2031F
  • Figure 17.United States Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 18.United States Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 19.United States Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 20.United States Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 21.United States Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 22.United States Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 23.United States Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 24.Canada Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 25.Canada Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 26.Canada Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 27.Canada Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 28.Canada Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 29.Canada Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 30.Canada Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 31.Mexico Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 32.Mexico Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 33.Mexico Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 34.Mexico Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 35.Mexico Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 36.Mexico Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 37.Mexico Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 38.Europe Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 39.Europe Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 40.Europe Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 41.Europe Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 42.Europe Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 43.Europe Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 44.Europe Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 45.Europe Infection Control Market Share (%), By Country, 2017-2031F
  • Figure 46.Germany Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.Germany Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 48.Germany Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 49.Germany Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 50.Germany Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 51.Germany Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 52.Germany Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 53.France Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 54.France Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 55.France Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 56.France Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 57.France Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 58.France Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 59.France Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 60.Italy Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 61.Italy Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 62.Italy Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 63.Italy Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 64.Italy Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 65.Italy Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 66.Italy Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 67.United Kingdom Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 68.United Kingdom Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 69.United Kingdom Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 70.United Kingdom Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 71.United Kingdom Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 72.United Kingdom Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 73.United Kingdom Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 74.Russia Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 75.Russia Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 76.Russia Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 77.Russia Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 78.Russia Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 79.Russia Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 80.Russia Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 81.Netherlands Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 82.Netherlands Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 83.Netherlands Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 84.Netherlands Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 85.Netherlands Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 86.Netherlands Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 87.Netherlands Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 88.Spain Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Spain Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 90.Spain Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 91.Spain Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 92.Spain Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 93.Spain Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 94.Spain Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 95.Turkey Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 96.Turkey Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 97.Turkey Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 98.Turkey Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 99.Turkey Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 100.Turkey Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 101.Turkey Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 102.Poland Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 103.Poland Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 104.Poland Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 105.Poland Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 106.Poland Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 107.Poland Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 108.Poland Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 109.South America Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 110.South America Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 111.South America Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 112.South America Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 113.South America Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 114.South America Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 115.South America Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 116.South America Infection Control Market Share (%), By Country, 2017-2031F
  • Figure 117.Brazil Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 118.Brazil Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 119.Brazil Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 120.Brazil Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 121.Brazil Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 122.Brazil Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 123.Brazil Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 124.Argentina Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 125.Argentina Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 126.Argentina Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 127.Argentina Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 128.Argentina Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 129.Argentina Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 130.Argentina Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 131.Asia-Pacific Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 132.Asia-Pacific Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 133.Asia-Pacific Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 134.Asia-Pacific Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 135.Asia-Pacific Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 136.Asia-Pacific Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 137.Asia- Pacific Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 138.Asia-Pacific Infection Control Market Share (%), By Country, 2017-2031F
  • Figure 139.India Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 140.India Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 141.India Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 142.India Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 143.India Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 144.India Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 145.India Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 146.China Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 147.China Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 148.China Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 149.China Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 150.China Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 151.China Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 152.China Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 153.Japan Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 154.Japan Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 155.Japan Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 156.Japan Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 157.Japan Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 158.Japan Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 159.Japan Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 160.Australia Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 161.Australia Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 162.Australia Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 163.Australia Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 164.Australia Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 165.Australia Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 166.Australia Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 167.Vietnam Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 168.Vietnam Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 169.Vietnam Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 170.Vietnam Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 171.Vietnam Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 172.Vietnam Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 173.Vietnam Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 174.South Korea Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 175.South Korea Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 176.South Korea Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 177.South Korea Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 178.South Korea Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 179.South Korea Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 180.South Korea Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 181.Indonesia Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.Indonesia Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 183.Indonesia Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 184.Indonesia Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 185.Indonesia Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 186.Indonesia Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 187.Indonesia Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 188.Philippines Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 189.Philippines Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 190.Philippines Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 191.Philippines Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 192.Philippines Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 193.Philippines Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 194.Philippines Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 195.Middle East & Africa Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 196.Middle East & Africa Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 197.Middle East & Africa Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 198.Middle East & Africa Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 199.Middle East & Africa Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 200.Middle East & Africa Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 201.Middle East & Africa Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 202.Middle East & Africa Infection Control Market Share (%), By Country, 2017-2031F
  • Figure 203.Saudi Arabia Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 204.Saudi Arabia Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 205.Saudi Arabia Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 206.Saudi Arabia Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 207.Saudi Arabia Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 208.Saudi Arabia Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 209.Saudi Arabia Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 210.UAE Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 211.UAE Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 212.UAE Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 213.UAE Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 214.UAE Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 215.UAE Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 216.UAE Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 217.South Africa Infection Control Market, By Value, In USD Billion, 2017-2031F
  • Figure 218.South Africa Infection Control Market, By Volume, In Million Units, 2017-2031F
  • Figure 219.South Africa Infection Control Market Share (%), By Type, 2017-2031F
  • Figure 220.South Africa Infection Control Market Share (%), By Product, 2017-2031F
  • Figure 221.South Africa Infection Control Market Share (%), By Application, 2017-2031F
  • Figure 222.South Africa Infection Control Market Share (%), By End-user, 2017-2031F
  • Figure 223.South Africa Infection Control Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 224.By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225.By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228.By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023